Doctor writing notes during consultation_AS

NICE guideline

NICE CKS—constipation in adults

2020-09-30T09:39:00+01:00By

This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title, it therefore only covers the information relevant to this setting, and is deliberately concise. Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information. Please refer to the full NICE guideline for the complete set of recommendations and references.

AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

2020-08-25T13:28:00+01:00By

The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.

Gastrointestinal tract_AS

NICE guideline

NICE CKS—diarrhoea

2020-03-26T10:04:00+00:00By

This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. For community pharmacists, the referral section implies primary care referral prior to secondary care referral. Please see the full guideline for the complete set ...

Doctor & baby 1 256x170

NICE guideline

NICE GORD in children guideline

2019-10-10T00:00:00+01:00By

A useful NICE guideline summary on the recognition, diagnosis, and management of GORD in children and young people.

GORD_resized_AS

NICE guideline

NICE GORD guideline

2019-10-01T09:00:00+01:00By

A brief NICE guidance summary on the investigation and management of dyspepsia and GORD including H pylori testing and eradication, and endoscopy referral.

Paediatrician doctor is examining child with stethoscope_AS

NICE guideline

NICE constipation in children guideline

2017-07-15T00:00:00+01:00By

A useful summary of NICE's guideline on the diagnosis and management of childhood constipation. Includes 'red flag' findings and summary tables.

Gut villi

NICE guideline

NICE IBS guideline

2017-04-20T00:00:00+01:00By

A summary of NICE guidance on the diagnosis and management of IBS in primary care. Includes dietary, lifestyle, pharmacological, and alternative approaches.

Abdomen

PHE/DH/DWP guideline

PHE infectious diarrhoea guideline

2015-08-17T00:00:00+01:00By

A concise summary of Public Health England guidance on managing suspected infectious diarrhoea. 

Doctor & baby 1 1701x1129

NICE guideline

NICE diarrhoea and vomiting in children guideline

2009-06-01T00:00:00+01:00By

A concise NICE guidance summary on diagnosis, assessment, and management of diarrhoea and vomiting caused by gastroenteritis in children under five years.

Resource hub

  • Simple steps for good bowel health

Educational resources

20201002 Rizmoic TA card V5 image

NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation

Commissioned by Sandoz Limited

The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information

UK/P/RZM/20-0016c October 2020

Management of opioid-induced constipation

The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)

Commissioned by Sandoz Limited

This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd. Information intended for UK healthcare professionals only. 
View prescribing information

UK/MKT/RZM/20-0029f October 2020

Dickman Webinar banner 3x22

Targeting the cause of opioid-induced constipation with PAMORAs

Commissioned by Sandoz Limited

This webinar has been initiated and commissioned by Sandoz Ltd and organised in partnership with Guidelines.
View prescribing information
UK/MKT/RZM/20-0032af

Doctors-with-ipad-and-device

Pancreatic exocrine insufficiency guideline

By Development group: Hambling Cummings Merriman & Widdowson

This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.